Literature DB >> 15821920

[Autologous serum versus hyaluronic acid eye drops for the treatment of corneal erosions after vitrectomy in diabetic patients. A prospective randomized study].

S Schulze1, W Sekundo, P Kroll.   

Abstract

PURPOSE: The purpose of this study was to evaluate whether treatment with autologous serum exhibits better epitheliotropic properties than hyaluronic acid in patients with reduced wound healing (diabetics). PATIENTS AND
METHOD: This prospective randomized study included all diabetic patients undergoing pars plana vitrectomy with abrasion of the corneal epithelium. In addition to the usual topical therapy one group was treated with hourly application of autologous serum, the other group with hyaluronic acid drops. We evaluated the time needed for closure of the corneal epithelium as well as other parameters such as patient's age, sex, duration of surgery, history of diabetes, and the current HbA1C.
RESULTS: There were 23 patients enrolled in the study. The epithelium healed a mean of 2 days earlier in the autologous serum group. Based on the statistically significant difference in favor of autologous serum, the study was terminated after treatment of 23 patients.
CONCLUSIONS: Autologous serum eye drops lead to earlier closure of the corneal epithelium after intraoperative abrasion in diabetic patients when compared with artificial tears.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15821920     DOI: 10.1007/s00347-005-1201-y

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  20 in total

1.  [Autologous serum for otherwise therapy resistant corneal epithelial defects - Prospective report on the first 70 eyes].

Authors:  R Ferreira de Souza; F E Kruse; B Seitz
Journal:  Klin Monbl Augenheilkd       Date:  2001-11       Impact factor: 0.700

2.  Treatment of recurrent corneal erosions using autologous serum.

Authors:  Jose Manuel Benítez del Castillo; Jose Maria Martínez de la Casa; Ricardo Cuiña Sardiña; Rosalia Méndez Fernández; Julian García Feijoo; Alfredo Castillo Gómez; Maria Matilla Rodero; Julian García Sánchez
Journal:  Cornea       Date:  2002-11       Impact factor: 2.651

3.  Prolonged exposure to high glucose impaired cellular behavior of normal human corneal epithelial cells.

Authors:  Hiroki Fujita; Ikuo Morita; Hiroshi Takase; Kyoko Ohno-Matsui; Manabu Mochizuki
Journal:  Curr Eye Res       Date:  2003-10       Impact factor: 2.424

4.  [Autologous serum-eye-drops for ocular surface disorders. A literature review and recommendations for their application].

Authors:  G Geerling; D Hartwig
Journal:  Ophthalmologe       Date:  2002-12       Impact factor: 1.059

5.  Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies.

Authors:  A C Poon; G Geerling; J K Dart; G E Fraenkel; J T Daniels
Journal:  Br J Ophthalmol       Date:  2001-10       Impact factor: 4.638

6.  Treatment of persistent corneal epithelial defect by autologous serum application.

Authors:  K Tsubota; E Goto; S Shimmura; J Shimazaki
Journal:  Ophthalmology       Date:  1999-10       Impact factor: 12.079

Review 7.  Autologous serum eye drops for ocular surface disorders.

Authors:  G Geerling; S Maclennan; D Hartwig
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

8.  Vitrectomy for proliferative diabetic retinopathy associated with vitreous hemorrhage.

Authors:  R Machemer; G Blankenship
Journal:  Ophthalmology       Date:  1981-07       Impact factor: 12.079

9.  Non-enzymatic glycation in corneas from normal and diabetic donors and its effects on epithelial cell attachment in vitro.

Authors:  Alison M McDermott; Tian L Xiao; Timothy S Kern; Christopher J Murphy
Journal:  Optometry       Date:  2003-07

10.  Frequency of epithelial debridement during diabetic vitrectomy.

Authors:  Thomas R Friberg; Masahito Ohji; Joseph J Scherer; Yasuo Tano
Journal:  Am J Ophthalmol       Date:  2003-04       Impact factor: 5.258

View more
  4 in total

1.  [On the use of autologous serum eyedrops in Germany : results of a survey among members of the Cornea Section of the German Ophthalmological Society (DOG)].

Authors:  K Kasper; L Godenschweger; D Hartwig; J D Unterlauft; B Seitz; G Geerling
Journal:  Ophthalmologe       Date:  2008-07       Impact factor: 1.059

Review 2.  [Albumin eye drops for treatment of ocular surface diseases].

Authors:  J D Unterlauft; M Kohlhaas; I Hofbauer; K Kasper; G Geerling
Journal:  Ophthalmologe       Date:  2009-10       Impact factor: 1.059

3.  [Recurrent corneal erosion. Different treatment options with the excimer laser with emphasis on aggressive PTK].

Authors:  P Eschstruth; W Sekundo
Journal:  Ophthalmologe       Date:  2006-07       Impact factor: 1.059

Review 4.  [Autologous serum and alternative blood products for the treatment of ocular surface disorders].

Authors:  G Geerling; J D Unterlauft; K Kasper; S Schrader; A Opitz; D Hartwig
Journal:  Ophthalmologe       Date:  2008-07       Impact factor: 1.059

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.